Induction of cytolytic anti-Gal antibodies in α-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria

Infection and Immunity

Volumn 70, Issue 11, 2002, Pages 6215-6222

  Posekany, Karla J ^a   Pittman, H Keith ^a   Bradfield, John F ^a   Haisch, Carl E ^a   Verbanac, Kathryn M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ANTIBODY; GALACTOSE ANTIBODY; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ISOPROTEIN; UNCLASSIFIED DRUG;

ABSORPTION; ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HYPERACUTE GRAFT REJECTION; INOCULATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; CYTOTOXICITY, IMMUNOLOGIC; DISACCHARIDES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; GALACTOSYLTRANSFERASES; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 0036840343     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.11.6215-6222.2002     Document Type: Article

References (39)

1. Apostolopoulos, V., M. S. Sandrin, and I. F. McKenzie. 1999. Carbohydrate/peptide mimics: effect on MUC1 cancer immunotherapy. J. Mol. Med. 77:427-436.
2. Avila, J. L., M. Rojas, and U. Galili. 1989. Immunogenic Gal α1-3Gal carbohydrate structures are present on pathogenic American Trypanosoma and Leishmania. J. Immunol. 142:2828-2834.
3. Chiang, T. R., L. Fanget, R. Gregory, Y. Tang, D. L. Ardiet, L. Gao, C. Meschter, A. P. Kozikowski, R. Buelow, and W. M. Vuist. 2000. Anti-Gal antibodies in humans and 1,3 α-galactosyl-transferase knockout mice. Transplantation 27:2593-2600.
4. Cretin, N., J. Bracy, K. Hanson, and J. Iacomini. 2002. The role of T-cell help in the production of antibodies specific for Gal α1-3Gal. J. Immunol. 168:1479-1483.
5. Davin, J. C., M. Malaise, J. Foidart, and P. Malieu. 1987. Anti-alpha-galactosyl antibodies and immune complexes in children with Henoch-Schonlein purpura or IgA nephropathy. Kidney Int. 31:1132-1139.
6. Galili, U., and P. Andrews. 1995. Suppression of α-galactosyl epitope synthesis and production of the natural anti-Gal antibody: a major evolutionary event in ancestral Old World primates. J. Hum. Evol. 29:433-442.
7. Galili, U., J. Buehler, S. B. Shohet, and B. A. Macher. 1987. The human natural anti-Gal IgG: the subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J. Exp. Med. 165:693-704.
8. Galili, U., M. R. Clark, S. B. Shohet, J. Buehler, and B. A. Macher. 1987. Evolutionary relationship between the natural anti-Gal antibody and the Gal a 1,3 Gal epitope in primates. Proc. Natl. Acad. Sci. USA 84:1369-1373.
9. Galili, U., and D. C. LaTemple. 1997. Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity. Immunol. Today 18:281-285.
10. Galili, U., R. E. Mandrell, R. M. Hamadeh, S. B. Shohet, and J. M. Grifiss. 1988. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 56:1730-1737.
11. Galili, U., S. B. Shohet, E. Kobrin, C. L. M. Stults, and B. A. Macher. 1988. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J. Biol. Chem. 263:17755-17762.
12. Hamadeh, R. M., M. M. Estabrook, P. Zhou, G. A. Jarvis, and J. M. Griffiss. 1995. Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing. Infect. Immun. 63:4900-4906.
13. Hamadeh, R. M., U. Galili, P. Zhou, and J. M. Griffiss. 1995. Anti-α-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. 1995. Clin. Diagn. Lab. Immunol. 2:125-131.
14. Hamadeh, R. M., G. A. Jarvis, U. Galili, R. E. Mandrell, P. Zhou, and J. M. Griffiss. 1992. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J. Clin. Investig. 4:1223-1235.
15. Joziasse, D. H., N. L. Shaper, D. Kim, D. H. van de Eijendent, and J. H. Shaper. 1992. Murine α 1,3 galactosyltransferase: a single gene locus specifies four isoforms of the enzyme by alternative splicing. J. Biol. Chem. 267:5534-5541.
16. Larson, R. D., C. A. Rivero-Marrero, L. K. Ernst, R. D. Cummings, and J. B. Lowe. 1990. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal (1,4)-D-GlcNac α (1,3) galactosyl transferase cDNA. J. Biol. Chem. 265:7055-7061.
17. LaTemple, D. C., J. T. Abrams, S. Y. Zhang, and U. Galili. 1999. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for α1,3-galactosyltransferase. Cancer Res. 115:3417-3423.
18. Love, S. D., W. Lee, Y. C. Nakamura, J. L. Platt, R. R. Bollinger, and W. Parker. 2001. Unexpected anti-αGalNAc antibodies in α-galactosyl transferase-deficient mice: complex relationship between genotype and the natural antibody repertoire. Immunobiology 203:650-658.
19. Mandelboim, O., E. Bar-Heim, E. Vadai, M. Fridken, and L. Eisenbach. 1997. Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas. J. Immunol. 159:6030-6036.
20. Manez, R., F. Blanco, I. Diaz, A. Centeno, E. Lopez-Pelaez, M. Hermida, H. Davies, and A. Katapodis. 2001. Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-galactosyl IgG antibodies. Xenotransplantation 8:15-23.
21. McKenzie, I. F. C., A. D. Thall, M. Sandrin, K. Patton, and Y. Q. Li. 1998. A murine model of antibody-mediated hyperacute rejection by galactose-α (1,3) galactose antibodies in Gal o/o mice. Transplantation 66:754-763.
22. Minanov, O., S. Itescue, F. Neethling, and A. Morganthaue. 1997. Anti-Gal antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation. Transplantation 63:182-186.
23. Parker, W., K. Lundberg-Swanson, Z. E. Holzknecht, J. Lateef, S. A. Washburn, S. L. Braedehoeft, and J. L. Platt. 1996. Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies. Hum. Immunol. 45:94-104.
24. Parker, W., P. B. Yu, Z. E. Holzknecht, K. Lundberg, R. H. Buckley, and J. L. Platt. 1997. Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development. J. Clin. Immunol. 17:311-321.
25. Pearse, M. J., E. Witort, P. Mottram, W. Han, L. Murray-Segal, M. Romanella, E. Salvaris, T. A. Shinkel, D. J. Goodman, and A. J. d'Apice. 1998. Anti-Gal antibody-mediated allograft rejection in α1,3 galactosyl transferase gene knockout mice. Transplantation 66:748-754.
26. Ramasamey, R., and R. Rajakanura. 1997. Association of malaria with inactivation of α1,3 galactosyl transferase in catarrhines. Biochim. Biophys. Acta 1360:241-246.
27. Reed, J. L., X. Lin, T. D. Thomas, C. W. Birks, J. Tang, and R. P. Rother. 1997. Alteration of glycosylation renders HIV sensitive to inactivation by normal human serum. J. Immunol. 159:4356-4361.
28. Sandrin, M. S., H. A. Vaughan, P. L. Dabkowski, and I. F. C. McKenzie. 1993. Anti-pig IgM antibodies in human serum react predominantly with Gal α(1,3)Gal epitopes. Proc. Natl. Acad. Sci. USA 90:11391-11395.
29. Sandrin, M. S., H. A. Vaughan, P. X. Xing, and I. F. McKenzie. 1997. Natural human anti-Gal α(1,3)Gal antibodies react with human mucin peptides. Glycoconjugate J. 14:97-105.
30. Springer, G. F., and R. E. Horton. 1969. Blood group isoantibody stimulation in man by feeding blood-group active bacteria. J. Clin. Investig. 48:1280-1291.
31. Takeuchi, Y., C. Porter, K. M. Strahan, A. F. Preece, K. Gustafsson, F. Cosset, R. A. Weiss, and M. K. L. Collins. 1996. Sensitization of cells and retroviruses to human serum by (α1,3) galactosyltransferase. Nature 379:85-88.
32. Tanemura, M., Dengping, Y., Chong, A. S., and U. Galili. 2000. Differential immune responses to α-Gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J. Clin. Investig. 105:301-310.
33. Thall, A. D., H. S. Murphy, and J. B. Lowe. 1996. α-1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant. Proc. 28:556-557.
34. Thall, A. D., P. Maly, and J. B. Lowe. 1995. Oocyte Gal α 1,3 Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 270:21437-21440.
35. Tremont-Lukats, I. W., J. L. Avila, D. Hernandez, J. Vasquez, M. Teixeira, and M. Rojas. 1996. Antibody levels against α-galactosyl epitopes in sera of patients with squamous intraepithelial lesions and early invasive cervical carcinoma. Gynecol. Oncol. 64:207-212.
36. Tremont-Lukats, I. W., J. L. Avila, F. Tapia, D. Hernandez, G. Caceres-Dittmar, and M. Rojas. 1996. Abnormal expression of galactosyl(α1-3) galactose epitopes in squamous cells of the uterine cervix infected by human papillomavirus. Pathobiology 64:239-246.
37. Vaughan, H. A., B. E. Loveland, and M. Sandrin. 1994. Gal α(1,3) Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies. Transplantation 58:879-882.
38. Welsh, R. M., C. L. O'Donnell, D. J. Reed, and R. P. Rother. 1998. Evaluation of the Gal α1,3 Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses. J. Virol. 72:4650-4656.
39. Wittels, E. G., and H. C. Lichtman. 1986. Blood group incidence and Escherichia coli bacterial sepsis. Transfusion 6:533-535.